focus -WSS

focus

author：knowledge 2025-09-27 21:54:52 - browse：141

Sage Therapeutics, a biotech developing an experimental treatment for postpartum depression, this week trumpeted strong results from a clinical trial, which cheered investors and pushed up its stock price. But outside the lab, the company’s aggressive efforts to raise awareness of postpartum depression have proved divisive.

The campaign’s message: “When it comes to postpartum depression, silence sucks.” It features close-up photos of distressed, tearful women who can’t speak — because they have pacifiers stuck in their mouths.

The images have been plastered on bus stops, buses, conference booths, and on a dedicated website. The ads don’t specifically mention Sage’s drug, which still needs further testing before the company can bring it to the Food and Drug Administration for possible approval. Instead, they urge women to talk “openly and honestly” about postpartum depression. An estimated 600,000 women in the U.S. alone experience symptoms, which range from insomnia and irritability to difficulty bonding with their baby.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Biogen says it will cut costs by $700 million, slash 1,000 jobs

WSS

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

How doctors’ personal politics affect patients

NIH chief: government has fallen behind pharma on clinical trials

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

FDA reorg will put new emphasis on investigations, sources say

The battle over 'scope creep' and who gets to be called 'doctor'

knowledge

focus

leisure time

Novavax promises a turnaround & Lilly roils the obesity market

CDC Director Mandy Cohen on transparency, trust, and health

Medicare proposal to cover medical devices draws a mixed reaction

Will the FTC rein in IQVIA's health data empire?

Jerome Adams on the need for new antivirals for Covid

Senate panel puts off hardest PBM reforms for another day

At least 13 dead in Texas as scorching temps continue

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Heart attack and stroke risk calculators need revising

Biogen says it will cut costs by $700 million, slash 1,000 jobs

focus

Cancer diagnosis changes perspective doctor, former hospital CEO

What causes rare myocarditis in young men after Covid vaccines?

Medical school prerequisites are outdated

What to watch for from Zogenix and Amicus clinical trials

White House drug czar issues call for 'recovery

Ohio still needs to do more to protect the right to abortion

focus

leisure time

hotspot

knowledge